nexium control 20mg gastro-resistant tablets
pfizer consumer healthcare ltd - esomeprazole magnesium trihydrate - gastro-resistant tablet - 20mg
nexium 20 mg gastro-resistant tablets
ltt pharma limited - esomeprazole magnesium trihydrate - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; esomeprazole
nexium 40 mg gastro-resistant tablets
ltt pharma limited - esomeprazole magnesium trihydrate - gastro-resistant tablet - 40 milligram(s) - proton pump inhibitors; esomeprazole
nexium 20 mg gastro-resistant tablets
lexon (uk) ltd - esomeprazole - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; esomeprazole
nexium 20 mg gastro-resistant tablets
lexon pharmaceuticals (ireland) limited - esomeprazole - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; esomeprazole
nexium
astrazeneca limited - esomeprazole magnesium trihydrate 22.3mg equivalent to 20 mg esomeprazole - film coated tablet - 20 mg - active: esomeprazole magnesium trihydrate 22.3mg equivalent to 20 mg esomeprazole excipient: crospovidone ferrous oxide glyceryl monostearate hard paraffin hyprolose hypromellose iron oxide yellow macrogol 6000 magnesium stearate methacrylic acid copolymer polysorbate 80 powdered cellulose purified talc sodium stearyl fumarate sugar spheres titanium dioxide triethyl citrate - nexium is highly effective in the treatment of acid related diseases and for the eradication of helicobacter pylori when given in combination with appropriate antibiotics. nexium is indicated for: gastro-oesophageal reflux disease (gord): ? treatment of erosive reflux oesophagitis ? long-term management of patients with healed oesophagitis to prevent relapse ? symptomatic treatment of gastro-oesophageal reflux disease (gord) in combination with appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: ? healing of helicobacter pylori associated duodenal ulcer and ? prevention of relapse of peptic ulcers in patients with helicobacter pylori associated ulcers
nexium
astrazeneca limited - esomeprazole magnesium trihydrate 44.5mg equivalent to 40 mg esomeprazole - film coated tablet - 40 mg - active: esomeprazole magnesium trihydrate 44.5mg equivalent to 40 mg esomeprazole excipient: crospovidone ferrous oxide glyceryl monostearate hard paraffin hyprolose hypromellose macrogol 6000 magnesium stearate methacrylic acid copolymer polysorbate 80 powdered cellulose purified talc sodium stearyl fumarate sugar spheres tekprint yellow sb3001 titanium dioxide triethyl citrate - nexium is highly effective in the treatment of acid related diseases and for the eradication of helicobacter pylori when given in combination with appropriate antibiotics. nexium is indicated for: gastro-oesophageal reflux disease (gord): ? treatment of erosive reflux oesophagitis ? long-term management of patients with healed oesophagitis to prevent relapse ? symptomatic treatment of gastro-oesophageal reflux disease (gord) in combination with appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: ? healing of helicobacter pylori associated duodenal ulcer and ? prevention of relapse of peptic ulcers in patients with helicobacter pylori associated ulcers
nexium esomeprazole magnesium capsule delayed release
cardinal health - esomeprazole magnesium (unii: r6dxu4way9) (esomeprazole - unii:n3pa6559ft) - esomeprazole 20 mg
nexium esomeprazole magnesium capsule delayed release
avera mckennan hospital - esomeprazole magnesium (unii: r6dxu4way9) (esomeprazole - unii:n3pa6559ft) - esomeprazole 20 mg
nexium esomeprazole magnesium capsule delayed release
unit dose services - esomeprazole magnesium (unii: r6dxu4way9) (esomeprazole - unii:n3pa6559ft) - esomeprazole 40 mg